In this week’s podcast episode, we are excited to welcome Doug Nissinoff, Managing Director and Founder at Intelligence Ventures as well as Principal and Founder at Renegade BioConsulting.
Intelligence Ventures emerged as a pioneering venture capital firm, dedicated to propelling innovation at the nexus of artificial intelligence and healthcare within the United States. Their focal point lies in strategically investing and nurturing pre-seed, seed, and Series A companies, fostering their growth and shaping the future of the industry.
Renegade BioConsulting, a global executive consultancy, specialises in international expansion, corporate communications, fundraising, and commercialization for companies within the Biotech, Pharma, and MedTech sectors.
In this episode, we delve into the dynamic world of healthcare and artificial intelligence. Tune in as our guest shares their remarkable career journey and insights at the intersection of these two transformative fields. Get ready for an in-depth analysis of the current landscape of venture capital and activities within the healthcare and AI industries. Discover the profound significance of AI in revolutionising the healthcare sector and unravel the investment strategies meticulously crafted by Intelligent Ventures. Gain valuable insights into the distinctions between the US and European investment markets, and explore the pivotal role played by VC firms in driving innovation. Learn about the crucial aspect of secondary investments and their impact on the industry.
Don’t miss out on this enlightening discussion packed with valuable perspectives and actionable takeaways!